NMS·Healthcare·$976M·#193 / 520 in Healthcare
LMRI Lumexa Imaging Holdings, Inc.
54SPECULATIVE
CATEGORY BREAKDOWN
GROWTH13
QUALITY27
STABILITY67
VALUATION100
GOVERNANCE97
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+7.8%
13
> 50% strong
Gross Margin
Revenue retained after direct costs
15.4%
21
> 50% strong
Cash Runway
Months of cash at current burn rate
999 months
100
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
164.2%
0
< 25% strong
Price / Sales
Market cap relative to trailing revenue
1.0x
100
< 3x strong
Rule of 40
Growth rate plus operating margin
10
36
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
81.0%
100
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+1.6%
90
< 5% ideal
RELATED STOCKS
COMPARE LMRI WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when LMRI's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.